The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: venlafaxine     Quarter: 2016Q3

Total Records: 1,160     Number of Pages: 58

DRUGNAME PT EventCount
VENLAFAXINE Sleep apnoea syndrome 8
VENLAFAXINE Vomiting 8
VENLAFAXINE HCL Condition aggravated 8
VENLAFAXINE HCL Drug interaction 8
VENLAFAXINE HCL Gait disturbance 8
VENLAFAXINE HCL Headache 8
VENLAFAXINE HCL Intentional product use issue 8
VENLAFAXINE HCL Muscular weakness 8
VENLAFAXINE HCL Weight decreased 8
VENLAFAXINE Abdominal discomfort 7
VENLAFAXINE Abdominal distension 7
VENLAFAXINE Aggression 7
VENLAFAXINE Altered state of consciousness 7
VENLAFAXINE Blood pressure increased 7
VENLAFAXINE Drug dose omission 7
VENLAFAXINE Feeling jittery 7
VENLAFAXINE Femoral neck fracture 7
VENLAFAXINE Galactorrhoea 7
VENLAFAXINE Hepatocellular injury 7
VENLAFAXINE Hot flush 7

Total Records: 1,160     Number of Pages: 58